IFITM Proteins Restrict Viral Membrane Hemifusion

PLoS Pathogens

Volumn 9, Issue 1, 2013, Pages

  Li, Kun ^a   Markosyan, Ruben M ^b   Zheng, Yi Min ^a   Golfetto, Ottavia ^c   Bungart, Brittani ^d   Li, Minghua ^a   Ding, Shilei ^e   He, Yuxian ^f   Liang, Chen ^e,g   Lee, James C ^d   Gratton, Enrico ^c   Cohen, Fredric S ^b   Liu, Shan Lu ^a  

^a University of Missouri   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MISSOURI   (United States)

^e MCGILL UNIVERSITY   (Canada)

^f INSTITUTE OF PATHOGEN BIOLOGY   (China)

^g MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CHLORPROMAZINE; INFLUENZA VIRUS HEMAGGLUTININ; INTERFERON; INTERFERON INDUCIBLE TRANSMEMBRANE; INTERFERON INDUCIBLE TRANSMEMBRANE 1; INTERFERON INDUCIBLE TRANSMEMBRANE 2; INTERFERON INDUCIBLE TRANSMEMBRANE 3; LAURDAN; MEMBRANE PROTEIN; OLEIC ACID; UNCLASSIFIED DRUG; VIRUS FUSION PROTEIN;

ARTICLE; CELL FUSION; CELL MEMBRANE; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; POLARIZATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SYNCYTIUM; VIRAL GENE DELIVERY SYSTEM; VIRION; VIRUS ATTACHMENT; VIRUS ENVELOPE; VIRUS INFECTION; WESTERN BLOTTING;

ANIMALS; ANTIGENS, DIFFERENTIATION; ANTIGENS, VIRAL; COS CELLS; CRICETINAE; CRICETULUS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS; JAAGSIEKTE SHEEP RETROVIRUS; PULMONARY ADENOMATOSIS, OVINE; SHEEP; VIRAL ENVELOPE PROTEINS; VIRUS INTERNALIZATION;

EID: 84875064947     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003124     Document Type: Article

References (70)

1. Sadler AJ, Williams BR, (2008) Interferon-inducible antiviral effectors. Nat Rev Immunol 8: 559-568.
2. Sheehy AM, Gaddis NC, Choi JD, Malim MH, (2002) Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418: 646-650.
3. Neil SJ, Zang T, Bieniasz PD, (2008) Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451: 425-430.
4. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, et al. (2004) The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427: 848-853.
5. Van Damme N, Goff D, Katsura C, Jorgenson RL, Mitchell R, et al. (2008) The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 3: 245-252.
6. Neil S, Bieniasz P, (2009) Human immunodeficiency virus, restriction factors, and interferon. J Interferon Cytokine Res 29: 569-580.
7. Malim MH, Emerman M, (2008) HIV-1 accessory proteins-ensuring viral survival in a hostile environment. Cell Host Microbe 3: 388-398.
8. Versteeg GA, Garcia-Sastre A, (2010) Viral tricks to grid-lock the type I interferon system. Curr Opin Microbiol 13: 508-516.
9. Loo YM, Gale M Jr, (2007) Viral regulation and evasion of the host response. Curr Top Microbiol Immunol 316: 295-313.
10. Stetson DB, Medzhitov R, (2006) Type I interferons in host defense. Immunity 25: 373-381.
11. Siegrist F, Ebeling M, Certa U, (2011) The small interferon-induced transmembrane genes and proteins. J Interferon Cytokine Res 31: 183-197.
12. Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, et al. (2009) The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139: 1243-1254.
13. Huang IC, Bailey CC, Weyer JL, Radoshitzky SR, Becker MM, et al. (2011) Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLoS Pathog 7: e1001258.
14. Weidner JM, Jiang D, Pan XB, Chang J, Block TM, et al. (2010) Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms. J Virol 84: 12646-12657.
15. Lu J, Pan Q, Rong L, Liu S-L, Liang C, (2010) The IFITM proteins inihibit HIV-1 infection. J Virol 85: 2126-2137.
16. Chan YK, Huang IC, Farzan M, (2012) IFITM proteins restrict antibody-dependent enhancement of dengue virus infection. PLoS One 7: e34508.
17. Jiang D, Guo H, Xu C, Chang J, Gu B, et al. (2008) Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus. J Virol 82: 1665-1678.
18. Feeley EM, Sims JS, John SP, Chin CR, Pertel T, et al. (2011) IFITM3 inhibits influenza A virus infection by preventing cytosolic entry. PLoS Pathog 7: e1002337.
19. Everitt AR, Clare S, Pertel T, John SP, Wash RS, et al. (2012) IFITM3 restricts the morbidity and mortality associated with influenza. Nature 484: 519-523.
20. Yount JS, Karssemeijer RA, Hang HC, (2012) S-Palmitoylation and Ubiquitination Differentially Regulate Interferon-induced Transmembrane Protein 3 (IFITM3)-mediated Resistance to Influenza Virus. J Biol Chem 287: 19631-19641.
21. Yount JS, Moltedo B, Yang YY, Charron G, Moran TM, et al. (2011) Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3. Nat Chem Biol 6: 610-614.
22. White JM, Delos SE, Brecher M, Schornberg K, (2008) Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit Rev Biochem Mol Bio 43: 189-219.
23. Harrison SC, (2008) Viral membrane fusion. Nat Struct Mol Biol 15: 690-698.
24. Kielian M, (2006) Class II virus membrane fusion proteins. Virology 344: 38-47.
25. Cohen FS, Melikyan GB, (2004) The energetics of membrane fusion from binding, through hemifusion, pore formation, and pore enlargement. J Membr Biol 199: 1-14.
26. Melikyan GB, Markosyan RM, Hemmati H, Delmedico MK, Lambert DM, et al. (2000) Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion. J Cell Biol 151: 413-423.
27. Côté M, Zheng YM, Albritton LM, Liu S-L, (2008) Fusogenicity of Jaagsiekte sheep retrovirus envelope protein is dependent on low pH and is enhanced by cytoplasmic tail truncations. J Virol 82: 2543-2554.
28. Côté M, Zheng YM, Albritton LM, Liu S-L, (2011) Single residues in the surface subunits of oncogenic sheep retrovirus envelopes distinguish receptor-mediated triggering for fusion at low pH and infection. Virology 421: 173-183.
29. Côté M, Zheng YM, Liu S-L, (2009) Receptor binding and low pH coactivate oncogenic retrovirus envelope-mediated fusion. J Virol 83: 11447-11455.
30. Côté M, Zheng YM, Li K, Xiang S-H, Albritton LM, et al. (2012) Critical Role of a Leucine-Valine Change in the Distinct Low pH Requirements for Membrane Fusion between Two Related Retrovirus Envelope. J Biol Chem 287: 7640-7651.
31. Mothes W, Boerger AL, Narayan S, Cunningham JM, Young JA, (2000) Retroviral entry mediated by receptor priming and low pH triggering of an envelope glycoprotein. Cell 103: 679-689.
32. Sharma NR, Mateu G, Dreux M, Grakoui A, Cosset FL, et al. (2011) Hepatitis C virus is primed by CD81 protein for low pH-dependent fusion. J Biol Chem 286: 30361-30376.
33. Côté M, Kucharski TJ, Liu S-L, (2008) Enzootic nasal tumor virus envelope requires a very acidic pH for fusion activation and infection. J Virol 82: 9023-9034.
34. Bertrand P, Côté M, Zheng YM, Albritton LM, Liu S-L, (2008) Jaagsiekte sheep retrovirus utilizes a pH-dependent endocytosis pathway for entry. J Virol 82: 2555-2559.
35. Friedman RL, Manly SP, McMahon M, Kerr IM, Stark GR, (1984) Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells. Cell 38: 745-755.
36. Goujon C, Malim MH, (2010) Characterization of the alpha interferon-induced postentry block to HIV-1 infection in primary human macrophages and T cells. J Virol 84: 9254-9266.
37. Xu Y, Yang G, Hu G, (2009) Binding of IFITM1 enhances the inhibiting effect of caveolin-1 on ERK activation. Acta Biochim Biophys Sin (Shanghai) 41: 488-494.
38. Parton RG, Richards AA, (2003) Lipid rafts and caveolae as portals for endocytosis: new insights and common mechanisms. Traffic 4: 724-738.
39. Andre B, Duterme C, Van Moer K, Mertens-Strijthagen J, Jadot M, et al. (2011) Hyal2 is a glycosylphosphatidylinositol-anchored, lipid raft-associated hyaluronidase. Biochem Biophys Res Commun 411: 175-179.
40. Rai SK, Duh FM, Vigdorovich V, Danilkovitch-Miagkova A, Lerman MI, et al. (2001) Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation. Proc Natl Acad Sci USA 98: 4443-4448.
41. Liu S-L, Duh FM, Lerman MI, Miller AD, (2003) Role of virus receptor Hyal2 in oncogenic transformation of rodent fibroblasts by sheep betaretrovirus env proteins. J Virol 77: 2850-2858.
42. Sherer NM, Lehmann MJ, Jimenez-Soto LF, Ingmundson A, Horner SM, et al. (2003) Visualization of retroviral replication in living cells reveals budding into multivesicular bodies. Traffic 4: 785-801.
43. Earp LJ, Delos SE, Park HE, White JM, (2005) The many mechanisms of viral membrane fusion proteins. Curr Top Microbiol Immunol 285: 25-66.
44. Leikina E, Chernomordik LV, (2000) Reversible merger of membranes at the early stage of influenza hemagglutinin-mediated fusion. Mol Biol Cell 11: 2359-2371.
45. White JM, Wilson IA, (1987) Anti-peptide antibodies detect steps in a protein conformational change: low-pH activation of the influenza virus hemagglutinin. J Cell Biol 105: 2887-2896.
46. Doxsey SJ, Sambrook J, Helenius A, White J, (1985) An efficient method for introducing macromolecules into living cells. J Cell Biol 101: 19-27.
47. Melikyan GB, Brener SA, Ok DC, Cohen FS, (1997) Inner but not outer membrane leaflets control the transition from glycosylphosphatidylinositol-anchored influenza hemagglutinin-induced hemifusion to full fusion. J Cell Biol 136: 995-1005.
48. Chernomordik LV, Frolov VA, Leikina E, Bronk P, Zimmerberg J, (1998) The pathway of membrane fusion catalyzed by influenza hemagglutinin: restriction of lipids, hemifusion, and lipidic fusion pore formation. J Cell Biol 140: 1369-1382.
49. Zavorotinskaya T, Qian Z, Franks J, Albritton LM, (2004) A point mutation in the binding subunit of a retroviral envelope protein arrests virus entry at hemifusion. J Virol 78: 473-481.
50. Chernomordik LV, Kozlov MM, (2005) Membrane hemifusion: crossing a chasm in two leaps. Cell 123: 375-382.
51. Chernomordik LV, Kozlov MM, (2008) Mechanics of membrane fusion. Nat Struct Mol Biol 15: 675-683.
52. Parasassi T, Gratton E, Yu WM, Wilson P, Levi M, (1997) Two-photon fluorescence microscopy of laurdan generalized polarization domains in model and natural membranes. Biophys J 72: 2413-2429.
53. Digman MA, Caiolfa VR, Zamai M, Gratton E, (2008) The phasor approach to fluorescence lifetime imaging analysis. Biophys J 94: L14-16.
54. Weber G, Farris FJ, (1979) Synthesis and spectral properties of a hydrophobic fluorescent probe: 6-propionyl-2-(dimethylamino)naphthalene. Biochemistry 18: 3075-3078.
55. Ilangumaran S, Hoessli DC, (1998) Effects of cholesterol depletion by cyclodextrin on the sphingolipid microdomains of the plasma membrane. Biochem J 335: 433-440.
56. Liu SY, Sanchez DJ, Cheng G, (2011) New developments in the induction and antiviral effectors of type I interferon. Curr Opin Immunol 23: 57-64.
57. Chernomordik LV, Kozlov MM, (2003) Protein-lipid interplay in fusion and fission of biological membranes. Annu Rev Biochem 72: 175-207.
58. Gaudin Y, (2000) Rabies virus-induced membrane fusion pathway. J Cell Biol 150: 601-612.
59. McMahon HT, Gallop JL, (2005) Membrane curvature and mechanisms of dynamic cell membrane remodelling. Nature 438: 590-596.
60. Richard JP, Leikina E, Langen R, Henne WM, Popova M, et al. (2012) Intracellular curvature-generating proteins in cell-to-cell fusion. Biochem J 440: 185-193.
61. Kozlovsky Y, Kozlov MM, (2002) Stalk model of membrane fusion: solution of energy crisis. Biophys J 82: 882-895.
62. von Heijne G, (2006) Membrane-protein topology. Nat Rev Mol Cell Biol 7: 909-918.
63. Lambert C, Prange R, (2001) Dual topology of the hepatitis B virus large envelope protein: determinants influencing post-translational pre-S translocation. J Biol Chem 276: 22265-22272.
64. Lundin M, Monne M, Widell A, Von Heijne G, Persson MA, (2003) Topology of the membrane-associated hepatitis C virus protein NS4B. J Virol 77: 5428-5438.
65. Smith RA, Young J, Weis JJ, Weis JH, (2006) Expression of the mouse fragilis gene products in immune cells and association with receptor signaling complexes. Genes Immun 7: 113-121.
66. Miller AD, Chen F, (1996) Retrovirus packaging cells based on 10A1 murine leukemia virus for production of vectors that use multiple receptors for cell entry. J Virol 70: 5564-5571.
67. Markosyan RM, Cohen FS, (2010) Negative potentials across biological membranes promote fusion by class II and class III viral proteins. Mol Biol Cell 21: 2001-2012.
68. Côté M, Zheng YM, Liu S-L, (2012) Membrane fusion and cell entry of XMRV are pH-independent and modulated by the envelope glycoprotein's cytoplasmic tail. PLoS One 7: e33734.
69. White J, Matlin K, Helenius A, (1981) Cell fusion by Semliki Forest, influenza, and vesicular stomatitis viruses. J Cell Biol 89: 674-679.
70. Jia B, Serra-Moreno R, Neidermyer W, Rahmberg A, Mackey J, et al. (2009) Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2. PLoS Pathog 5: e1000429.